Get started
Author

Jonathan Kitonsa

Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda
2020 · Julius Kiwanuka, Jacinta Mukulu Waila, et al. · PLoS ONE · 87
PDF
Knowledge, Attitudes, and Practices Regarding COVID-19 among Healthcare Workers in Uganda: A Cross-Sectional Survey
2021 · Onesmus Kamacooko, Jonathan Kitonsa, et al. · International Journal of Environmental Research and Public Health · 76
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda
2021 · Jonathan Kitonsa, Onesmus Kamacooko, et al. · PLoS ONE · 28
PDF
The impact of the COVID-19 pandemic on the provision & utilisation of primary health care services in Goma, Democratic Republic of the Congo, Kambia district, Sierra Leone & Masaka district, Uganda
2023 · K Kasonia, D Tindanbil, et al. · PLoS ONE · 18
PDF
Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda
2019 · Jonathan Kitonsa, Yunia Mayanja, et al. · PLoS ONE · 16
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda
2020 · Jonathan Kitonsa, Abu-Baker Ggayi, et al. · Global Health Action · 13
PDF
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size
2022 · Thomas A Rasmussen, Sunil K Ahuja, et al. · Clinical Infectious Diseases · 11
PDF
Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda
2020 · Jonathan Kitonsa, Rebecca Nsubuga, et al. · PLoS neglected tropical diseases · 11
PDF
Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda
2023 · Jonathan Kitonsa, Sheila Kansiime, et al. · Global Health Action · 8
PDF
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals
2025 · Jonathan Kitonsa, Jennifer Serwanga, et al. · Vaccines · 6
PDF
Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda
2022 · Anita Kabarambi, Sheila Kansiime, et al. · International Journal of Environmental Research and Public Health · 6
PDF
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study
2023 · Bolarinde J. Lawal, Katherine E. Gallagher, et al. · International Journal of Infectious Diseases · 5
COVID-19 Vaccine Acceptability Among Healthcare Facility Workers in Sierra Leone, the Democratic Republic of Congo and Uganda: A Multi-Centre Cross-Sectional Survey
2022 · Hilary S. Whitworth, Jonathan Kitonsa, et al. · International Journal of Public Health · 5
Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA)
2025 · Victoria Babirye Tumusiime, Eugene Ruzagira, et al. · Wellcome Open Research · 4
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4
PDF
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences
2023 · Jonathan Kitonsa, Onesmus Kamacooko, et al. · Human Vaccines & Immunotherapeutics · 3
PDF
The immediate treatment outcomes and cost estimate for managing clinical measles in children admitted at Mulago Hospital: A retrospective cohort study
2023 · Barbara Namugga, Ombeva Malande, et al. · PLOS Global Public Health · 3
PDF
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)
2022 · Eleftherios Mylonakis, Joseph Lutaakome, et al. · Med · 3
PDF
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis
2021 · Jonathan Kitonsa, Julius Kiwanuka, et al. · PLoS neglected tropical diseases · 3
PDF
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial
2025 · Ahmad Mourad, Gregory A. Grandits, et al. · Clinical Microbiology and Infection · 2
PDF
“Resilience amidst challenges”: Healthcare users’ experiences of access and utilisation of primary healthcare services during the COVID-19 pandemic in southwestern Uganda
2025 · Rachel Kawuma, Joseph Katongole, et al. · PLOS Global Public Health · 1
PDF
Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials
2024 · Paola del Carmen Guerra-de-Blas, Rubria Marines-Price, et al. · Journal of Clinical and Translational Science · 1
PDF
Works count: 38
Citation count: 419
H-index: 11
I10-index: 11
Year
Topic
Type